Pharmacokinetics (PK) is essential for understanding how the body absorbs, distributes, metabolizes, and eliminates a drug. At Veeda Biopharma, our expert, Dr. Jagadeesh Boda, Ph.D., Head of Clinical Bioanalysis, highlights how PK assessments guide dose escalation and optimization in clinical studies by considering both patient-related factors and drug properties. Explore how Veeda Biopharma integrates PK and Pharmacodynamics (PD) to provide comprehensive insights into drug behavior and effects. Webinar Recording Link: https://bit.ly/4dBXWYg For more on our PK/PD expertise, contact us at [email protected] or visit www.veedacr.com Partners in creating a healthier tomorrow. #VeedaBiopharma #Pharmacokinetics #Pharmacodynamics #ClinicalStudies #DrugDevelopment #VeedaExpert #Veeda
Veeda Clinical Research Limited
Research Services
Ahmedabad, Gujarat 63,784 followers
Global Clinical Development Partner- Providing Quality Clinical Research Solutions
About us
Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a comprehensive portfolio of clinical, preclinical and bio/analytical services to support innovator, biosimilar and generic drug development programs of our global clientele. We are an independent, institutional investors owned, Board governed and professionally managed contract research group offering scientific leadership, global quality management systems and long term operational and financial stability through a continuing investment in our people, processes, systems, infrastructure and technology and a deep commitment to quality. Together, we serve clients globally in the following industries: ● Pharmaceutical and Biopharmaceutical ● Agrochemical and Industrial Chemicals ● Herbal/Nutraceuticals ● Medical Devices
- Website
-
https://veedacr.com
External link for Veeda Clinical Research Limited
- Industry
- Research Services
- Company size
- 501-1,000 employees
- Headquarters
- Ahmedabad, Gujarat
- Type
- Privately Held
- Founded
- 2004
- Specialties
- BA/BE Studies, Central Bioanalytical Services, First-in-Man Studies , Biosimilars , Clinical Data Management, Phase 2 trials, Phase 3 Trials, biologics, biostatistics, early phase trials, pharmacovigilance, late phase trials, preclinical research & development, and Phase 1 trials
Locations
Employees at Veeda Clinical Research Limited
Updates
-
Is Your Inhalation Drug Portfolio Ready for the Upcoming Patent Cliff? The market for inhaled drugs is on the rise, driven by the increasing prevalence of respiratory diseases. This growth presents significant opportunities for the industry to expand and innovate. Veeda Group is a leader in inhalation drug delivery, having conducted 42 studies across 7 different inhalation delivery methods, including pressurized metered dose inhalers and dry powder inhalers. Our experts are specially trained to ensure the correct use of these devices, addressing common challenges such as improper usage and coordination of actuation and inhalation. Their deep knowledge covers the structural and mechanical aspects of aerosol delivery devices, mechanisms of aerosol generation, formulation compatibility, and the advantages and limitations of different devices. To learn more about our Inhalation Drug Development services, reach out to us at [email protected] or visit our website at www.veedacr.com. Partners in creating a healthier tomorrow. #Veeda #VeedaCR #VeedaGroup #VeedaBiopharma #Biopharma #DrugDevelopment #ClinicalResearch #InhalationDrug
-
-
Veeda Group engages with global vaccine leaders at the 3rd Indian Vaccine Leaders Conclave at Pune, India. Group CEO and MD, Dr. Mahesh Bhalgat delivered a talk and presentation on “Vaccines: Taking on the world” addressing the gathering of delegates and senior leadership dignitaries from the vaccine industry. The central focus of his talk and presentation explore recent Innovations & developments, challenges, and opportunities in the field of vaccines, and showcasing the crucial role of Contract Research Organizations in building futuristic vaccines with the help of technology and innovation. During his conversation with industry leaders, Dr. Mahesh highlighted India’s significant contribution to global vaccine innovation and public health. He emphasized on implementing innovative practices in vaccine research and development as well as increasing use of technologies that collectively enhance the speed, accuracy, and efficacy of vaccine development, ensuring rapid responses to emerging infectious diseases. The 3rd edition of Indian Vaccine Leaders Conclave focused on meaningful theme of “Advancement in Vaccine Innovations” & witnessed participation from leading global specialists including researchers, scientists, academicians, vaccinologists, immunologists, health care professionals, clinicians, government representatives & industry delegates, who shared knowledge on vaccine industry’s most recent ground-breaking advancements & discoveries. Tandon, Ajay Sivakumar Vaidyanathan Sanjib Banerjee, PhD Rajkumar Agarwal Gaurav Tinani Dr Ravi Alamchandani Dr Rakesh Patel Gamlendra (Gamu) Mishra Sapna Y. R. BIONEEDS INDIA PRIVATE LIMITED Heads BlueTech Media Anita Shete-Aich Anish Chakkumkal , PhD Mukesh Mahajan Rajni Jha Vikram Mahapatra Rajesh Kumar Chopra Nupur Sengupta, PhD, MBA Dr. VAIBHAV DUBEY Rajendar Burki, PhD Dr. Vinod Pantula Dr. Subhash Thuluva Dr Santosh Taur, MD, DM, CMD Dharmesh Kharwar Kedar Suvarnapathaki Dr.Balakota Reddy P Satyendra Kumar Guddeti Dr. Hitt Sharma Ashish Sahai pharmabiz.com BioSpectrum India Express Pharma The Economic Times The Business Standard BioVoice News
-
-
-
-
-
+13
-
-
Veeda Biopharma's Strategy for Tocilizumab PK Assay Development: At Veeda Biopharma, we tackle the complexities of developing PK assays for monoclonal antibodies like Tocilizumab with a comprehensive approach. Our strategy includes a highly specific bridging ELISA format, optimized to reduce matrix interference, and required assay range with high sensitivity. Our dedicated team of scientists has meticulously crafted this process, incorporating anti-idiotypic antibody pairs and optimizing the Minimum Required Dilution (MRD) to enhance selectivity and accuracy by ensuring consistent and reliable performance. Beyond Tocilizumab, our expertise in developing custom assays for a wide range of compounds and therapeutic modalities. Whether you're working with monoclonal antibodies, fusion proteins, or other complex biologics, we provide tailored solutions to meet your specific needs, ensuring robust data and regulatory compliance. For more information on how we can support your assay development needs, contact us at [email protected] or visit www.veedacr.com. Stay tuned for more updates and insights from Veeda Biopharma! Partners in creating a healthier tomorrow. #Tocilizumab #PKAssay #VeedaBiopharma #Pharmacokinetics #Biopharma #DrugDevelopment #ELISA #ClinicalResearch #Biotechnology #CustomAssays
-
Corporate Social Responsibility and Community Engagement at Veeda Group! Our belief in fostering human progress drives us to actively address the challenges faced by the communities we serve. As a responsible corporate citizen, we prioritize initiatives that create a lasting positive impact. Creating Essential Infrastructure: Access to clean water is fundamental to health and well-being. To support this essential need, Veeda Group is dedicated to building robust infrastructure. Our efforts focus on providing: - Water Tanks: Ensuring a reliable water supply for schools and colleges, especially in areas facing scarcity. - Water Coolers: Promoting hydration and health among students by providing clean drinking water facilities. - RO Systems: Delivering safe and purified water for consumption, contributing to overall hygiene and well-being. BIONEEDS INDIA PRIVATE LIMITED Heads Partners in creating a healthier tomorrow #Veeda #VeedaGroup #CSR #VeedaClinicalResearch #ClinicalTrials #CommunityEngagement #RobustInfrastructure
-
-
-
-
-
+2
-
-
𝐓𝐢𝐧𝐲 𝐒𝐚𝐦𝐩𝐥𝐞𝐬, 𝐁𝐢𝐠 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐬! Microsampling is revolutionizing bioanalysis by making testing faster, more efficient, and patient-friendly with minimal sample volume. This approach is particularly invaluable in pharmacokinetic studies, especially for vulnerable populations like children and animals, where it reduces sample volume requirements, minimizing discomfort and ethical concerns. Veeda Group optimizes large-scale studies through advanced microsampling techniques. Our high-throughput analysis ensures rapid sample processing, accelerating drug development with precise and reliable data generation To know more about our microsampling techniques write to us at [email protected] or visit us at www.veedacr.com Partners in Creating a Healthier Tomorrow. #Veeda #VeedaGroup #VeedaCR #VeedaClinicalResearch #Microsampling #MicrosamplingTechniques #Bioanalysis
-
Veeda's engagement with global vaccine leaders Dr. Mahesh Bhalgat, Group CEO and MD of Veeda to deliver keynote address at the 3rd edition of India Vaccine Leaders Conclave 2024, which features eminent dignitaries from the global vaccine industry. India launched world's biggest vaccination drive during the COVID 19 pandemic and today, the country is poised to take a giant leap in the global vaccine development. Please join and visit India Vaccine Conclave 2024 at Pune, India on August 23 to listen Dr. Mahesh speak on India's innovation success in vaccine development and how CROs are disrupting the growth story of vaccine industry. https://lnkd.in/d8Xw5tA2 #VaccineDevelopment #contractresearch #growthstory #researchanddevelopment
🌟 Exciting Announcement: Meet Our Esteemed Speakers and Partners for the IVLC - India Vaccine Leaders Conclave 2024 in Pune! 🌟 We are thrilled to introduce the brilliant minds and industry leaders who will be shaping the future of vaccines and healthcare at this year’s conclave. Get ready for insightful discussions, innovative ideas, and powerful collaborations that will drive impactful change in the vaccine landscape. 👉 Register now: https://lnkd.in/dn8bAkkN Join us for an insightful event themed “Advancement in Vaccine Innovation,” where leading experts, researchers, scientists, and industry professionals from around the globe will gather to share the latest groundbreaking advancements and discoveries in the field of vaccines. Why Attend: 🔍 Gain strategic insights from Vaccine Manufacturers & Biopharma professionals 🧠 Learn from case studies, presentations, and interactive panel discussions 🔬 Discuss challenges in Tech Transfer, Quality Control, R&D, and clinical trials 🌐 Enhance your knowledge of regulatory perspectives and global harmonization 🤝 Network with the Vaccine & Biopharma community Who Will Attend: • Vaccine Manufacturing Companies • Vaccine R&D Teams • Clinical Trial Experts • Executives (CEO/CSO/President/VP/GM/AGM) • Quality Control & Regulatory Affairs Specialists • Marketing Professionals • And many more! Key Topics: • Partnerships in Vaccine R&D • Emerging Trends in Vaccine Delivery Systems & Adjuvants • Quality Control in Vaccine Manufacturing • Global Vaccine Distribution & Access • Navigating Vaccine Regulatory Pathways Don't miss this unique opportunity to connect with industry leaders and expand your professional network. 👉 Register now: https://lnkd.in/dn8bAkkN
-
-
Tricolours were hoisted at the dawn of August 15, 2024 as Veeda celebrated the 78th Independence day of India. All site locations of Veeda in India across Gujarat (Ahmedabad and Mehsana) and Karnataka (Bengaluru) were decorated using the national flag colours with tri-color ribbons, balloons and employees from all site locations gathered to pay respect and honour the ever-growing legacy of our heroes who fought for India’s freedom. The flag hoisting ceremony was followed by singing of national anthem and employees whole-heartedly participated in playful group activities at the site location. The spirit of nationalism unites every Veeda employee to work towards its goal of improving and making a difference in the lives of people by creating a healthier tomorrow. #Veeda #VeedaCR #VeedaClinicalResearch #IndependenceDayCelebration #FlagHoisting Tandon, Ajay Pranav Dalal Abhiram Gudu Manmohansinh Chauhan Sivakumar Vaidyanathan Sanjib Banerjee, PhD BIONEEDS INDIA PRIVATE LIMITED Heads
-
-
-
-
-
+2
-
-
Happy Independence Day from the Veeda Group! Let's cherish our freedom, inspire change, and build a stronger nation together. Write to us at [email protected] or visit us at www.veedacr.com Partners in Creating a Healthier Tomorrow. BIONEEDS INDIA PRIVATE LIMITED Heads #IndependenceDay2024 #Veeda #VeedaGroup #VeedaCR #VeedaClinicalResearch
-
-
𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐢𝐭𝐲: 𝐀 𝐒𝐭𝐞𝐩𝐰𝐢𝐬𝐞 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐥𝐨𝐠𝐲 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡 "In the process of establishing biosimilarity, Clinical Pharmacology plays a pivotal role, particularly through bioanalytical assays. These studies build upon comparative analytical data to ensure no clinically meaningful differences between the biosimilar and the reference product." "As explained by Jagadeesh Boda, Ph.D., Head of Clinical Bioanalysis at Veeda, this stepwise approach addresses any residual uncertainties, guides subsequent clinical testing, and solidifies the demonstration of biosimilarity." Webinar Recording Link: https://bit.ly/4dBXWYg To know more about our upcoming Live Webinars write to us at [email protected] or visit us at www.veedacr.com Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #VeedaCR #Biosimilars #ClinicalPharmacology #Bioanalysis #DrugDevelopment #VeedaExpert